Diagnosis and Precision in Breast Cancer
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 2211
Special Issue Editor
Special Issue Information
Dear Colleagues,
Based on WHO data from 2019, malignant diseases are the first or second most frequent cause of morbidity in people under 70 years of age in 112 countries, and for women in most parts of the world, breast cancer is one of the leading causes of death, with rising incidence. Advances in diagnostics have led to early detection followed by decreasing breast cancer mortality. Precision in detecting and treating breast cancer can relate to any part of patient care, from tailoring diagnostic and individualized treatments such as surgery, systemic therapy and radiotherapy, to long-term survivorship, relying on evidence, clinical practice and detailed disease characterization, and thus, providing the right therapy, to the right person, at the right time. Although there have been impressive advances in precision oncology over the past decade, especially in the field of molecular characterization and the tumor microenvironment, the potential effects of precision medicine have not yet produced the desired results. In this Special Issue of Diagnostics, we want to address the diagnostic modalities that could help medical professionals tailor an individual approach to patients with breast cancer. We welcome all manuscripts that focus on: the individualization of diagnostic methods, determining personalized screening for high-risk populations, family gene burden, tumor heterogeneity, tailored treatment, predictive tools for optimizing therapy, and the use of artificial intelligence.
Dr. Marko Spasic
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- diagnostics
- personalized medicine
- tumor heterogeneity
- individualized treatment
